Can Wegovy Cause Ovarian Cysts? What the Evidence Shows

Is there any evidence that Wegovy directly causes ovarian cysts?

Not from the data we have. The STEP 1 trial, which followed 1,961 adults over 68 weeks on semaglutide 2.4mg alongside lifestyle changes, did not flag ovarian cysts as a treatment-related adverse event. Wider post-marketing safety data collected since Wegovy's UK approval has also not produced a signal linking semaglutide to cyst formation. The NHS semaglutide medicines page sets out the recognised side effects of the drug (it is worth reading it in full) and ovarian cysts do not appear there.

That does not mean every symptom a woman experiences on Wegovy is unrelated to the medicine. It means there is no established mechanism or repeated observation connecting semaglutide specifically to cyst development. GLP-1 receptors are present in various tissues beyond the gut, and research into their full physiological role is ongoing. But treating an absence of evidence as evidence of absence is exactly the kind of reasoning that makes a clinical conversation more useful than a forum thread.

Worth keeping in mind: many women starting Wegovy are in their thirties or forties, an age when functional ovarian cysts are relatively common regardless of any medication. A cyst found during treatment is not automatically caused by the treatment.

Why does weight loss itself sometimes affect ovarian health?

Body fat produces and stores oestrogen. When weight falls meaningfully over a short period, circulating oestrogen can shift, and the hormonal balance that governs the menstrual cycle temporarily adjusts. This is not unique to Wegovy, it happens with any effective weight-loss intervention, including dietary changes and bariatric surgery.

For some women, particularly those with semaglutide-related questions about PCOS, the picture is more complex. PCOS involves insulin resistance, elevated androgens and disrupted ovulation, and excess weight often makes all three worse. As weight falls and insulin sensitivity improves, ovulation can resume or change frequency. Resuming ovulation after a period of anovulation can, in some cases, produce follicular cysts as the ovary starts cycling again. This is a recognised consequence of weight loss and improved metabolic health, not a drug effect.

None of this should be self-diagnosed. If your cycle has changed noticeably or you are experiencing pelvic discomfort, a GP can arrange an ultrasound and hormone panel. That is the only reliable way to know what is happening.

What symptoms should prompt you to get medical help?

Wegovy's most common side effects are gastrointestinal, nausea, loose stools, reflux, and similar. If you want a fuller picture of how the GI profile typically presents, the bloating and gas page and the broader Wegovy side-effect overview cover the detail. Pelvic pain is not in that group.

Seek medical attention promptly if you develop:

• Sudden or severe lower abdominal or pelvic pain.
• Pain during sex or on one side of the abdomen.
• Abnormal vaginal bleeding or a significantly disrupted cycle that was previously regular.
• Bloating that feels different from the usual Wegovy digestive effects, persistent, localised and unrelated to meals.

These are symptoms of potential gynaecological conditions (ovarian cysts, torsion, endometriosis or others) that require assessment in their own right. Do not wait to see whether they settle. The MHRA's Yellow Card scheme also exists so that patients can report suspected side effects of any medicine, and doing so genuinely contributes to post-marketing safety monitoring.

Does any of this change who Wegovy is suitable for?

Not based on current evidence. Wegovy is licensed for adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A history of PCOS is not a contraindication, and in practice women with PCOS and obesity are often strong candidates for weight-management treatment given how closely their condition is tied to metabolic factors. You can read more on the Wegovy treatment page or explore weight-loss treatment options more broadly.

Every prescription is preceded by a full clinical assessment. A real prescriber reads through your health history (including gynaecological conditions) before any treatment is approved. If you are wondering whether your specific history makes Wegovy suitable, that assessment is the place to get a considered answer rather than a general one. Some women also ask about unexpected weight changes on Wegovy or other unfamiliar symptoms, and people curious about whether Wegovy can cause erectile dysfunction will find that question answered alongside other common concerns in our FAQs page, which covers a range of questions from people already on treatment.

If you have concerns that feel more pressing or personal than a page like this can address, our team is reachable seven days a week. And if you are ready to understand whether Wegovy is right for you, speak to our prescribers through a free consultation at any time.